Clinical Trials in Boston

Showing 12381-12400 of 17,836 trials

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

NCT00006025

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of temozolomide plus irinotecan in treating patients who have recurrent malignant glioma.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Jan 2001

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +6 more locations

COMPLETEDPhase 2< 1 mile

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

NCT00006358

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Thalidomide may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and thalidomide in treating patients who have recurrent or progressive brain tumor.

Brain and Central Nervous System Tumors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins44 participantsStarted Jun 2000

Los Angeles, California, United States • San Francisco, California, United States • Bethesda, Maryland, United States +8 more locations

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Find Trials by Condition in Boston

Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Effects of Perioperative Nesiritide or Milrinone Infusion on Recovery From Fontan Surgery

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Evaluation Of The Total Face Mask For Emergency Application In Acute Respiratory Failure

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children

A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

A Fixed Dose, Dose Response Study for Ropinirole Prolonged Release in Patients With Early Stage Parkinson's Disease

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN®

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets